John W Smither Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John W Smither.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John W Smither. John W Smither is Director in Achaogen Inc ($AKAO) and Chief Financial Officer in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and Director in Principia Biopharma Inc. ($PRNB) and Chief Financial Officer in Sienna Biopharmaceuticals, Inc. ($SNNA) and Chief Financial Officer in Arcutis Biotherapeutics, Inc. ($ARQT).
Latest Insider Trading Transactions of John W Smither
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ARQT, KYTH, PRNB, SNNA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 44,982 | |
| Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 32.90 | 1,250 | 41,125 | 86,715 | 88 K to 86.7 K (-1.42 %) |
| Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 32.90 | 500 | 16,450 | 46,321 | 46.8 K to 46.3 K (-1.07 %) |
| Mar 11 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 46,821 | 46.3 K to 46.8 K (+1.08 %) |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 12,396 | 20,833 | 97,684 | |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | A | 32.44 | 28,800 | 934,272 | 28,800 | |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 12,396 | 20,833 | 46,321 | 33.9 K to 46.3 K (+36.54 %) |
| Mar 05 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Grant | A | 0.00 | 9,500 | 0 | 33,925 | 24.4 K to 33.9 K (+38.89 %) |
| Mar 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 34.20 | 773 | 26,440 | 24,425 | 25.2 K to 24.4 K (-3.07 %) |
| Mar 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 34.20 | 773 | 26,440 | 24,425 | 25.2 K to 24.4 K (-3.07 %) |
| Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 750 | 1,260 | 45,482 | |
| Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.64 | 2,000 | 71,280 | 87,965 | 90 K to 88 K (-2.22 %) |
| Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.64 | 750 | 26,730 | 25,198 | 25.9 K to 25.2 K (-2.89 %) |
| Feb 12 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 750 | 1,260 | 25,948 | 25.2 K to 25.9 K (+2.98 %) |
| Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 1,250 | 2,101 | 46,232 | |
| Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.00 | 3,750 | 131,250 | 89,965 | 93.7 K to 90 K (-4.00 %) |
| Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 35.00 | 1,250 | 43,750 | 25,198 | 26.4 K to 25.2 K (-4.73 %) |
| Feb 03 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 1,250 | 2,101 | 26,448 | 25.2 K to 26.4 K (+4.96 %) |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 47,482 | |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 47,482 | |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,250 | 37,500 | 93,715 | 95 K to 93.7 K (-1.32 %) |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,250 | 37,500 | 93,715 | 95 K to 93.7 K (-1.32 %) |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 500 | 15,000 | 25,198 | 25.7 K to 25.2 K (-1.95 %) |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 500 | 15,000 | 25,198 | 25.7 K to 25.2 K (-1.95 %) |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 25,698 | 25.2 K to 25.7 K (+1.98 %) |
| Jan 21 2021 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 25,698 | 25.2 K to 25.7 K (+1.98 %) |
| Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 1,500 | 2,521 | 47,982 | |
| Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 3,750 | 112,500 | 94,965 | 98.7 K to 95 K (-3.80 %) |
| Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,500 | 45,000 | 25,198 | 26.7 K to 25.2 K (-5.62 %) |
| Dec 16 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 1,500 | 2,521 | 26,698 | 25.2 K to 26.7 K (+5.95 %) |
| Oct 01 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 500 | 840 | 49,482 | |
| Oct 01 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 1,250 | 37,500 | 98,715 | 100 K to 98.7 K (-1.25 %) |
| Oct 01 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 500 | 15,000 | 23,875 | 24.4 K to 23.9 K (-2.05 %) |
| Oct 01 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 500 | 840 | 24,375 | 23.9 K to 24.4 K (+2.09 %) |
| Jun 15 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.68 | 14,875 | 24,999 | 110,080 | |
| Jun 15 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Buy | M | 1.68 | 14,875 | 24,999 | 123,840 | 109 K to 123.8 K (+13.65 %) |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Option Exercise | A | 27.61 | 12,000 | 331,320 | 12,000 | |
| Mar 03 2020 | ARQT | Arcutis Biotherape ... | Smither John W | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 108,965 | 100 K to 109 K (+9.00 %) |
| Feb 21 2019 | PRNB | Principia Biopharm ... | Smither John W | Director | Option Exercise | A | 30.30 | 20,475 | 620,393 | 20,475 | |
| Jul 17 2018 | SNNA | Sienna Biopharmace ... | Smither John W | Chief Financial Off ... | Option Exercise | A | 16.90 | 20,000 | 338,000 | 20,000 | |
| Jun 07 2018 | AKAO | Achaogen Inc | Smither John W | Director | Option Exercise | A | 12.07 | 15,000 | 181,050 | 15,000 | |
| Apr 18 2018 | SNNA | Sienna Biopharmace ... | Smither John W | Chief Financial Off ... | Option Exercise | A | 19.59 | 170,000 | 3,330,300 | 170,000 | |
| Jun 16 2017 | AKAO | Achaogen Inc | Smither John W | Director | Option Exercise | A | 22.11 | 10,000 | 221,100 | 10,000 | |
| Jun 17 2016 | AKAO | Achaogen Inc | Smither John W | Director | Option Exercise | A | 4.84 | 10,000 | 48,400 | 10,000 | |
| Oct 02 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | D | 38.53 | 45,344 | 1,747,104 | 0 | |
| Oct 02 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | D | 44.02 | 19,266 | 848,089 | 0 | |
| Oct 02 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | D | 27.50 | 6,700 | 184,250 | 0 | |
| Oct 02 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | D | 8.22 | 852 | 7,003 | 0 | |
| Oct 02 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | D | 5.90 | 14,897 | 87,892 | 0 | |
| Oct 02 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | D | 0.00 | 6,216 | 0 | 0 | 6.2 K to 0 (-100.00 %) |
| Oct 02 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | D | 0.00 | 17,960 | 0 | 0 | 18 K to 0 (-100.00 %) |
| Sep 28 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 4.84 | 14,017 | 67,842 | 0 | |
| Sep 28 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 4.84 | 14,017 | 67,842 | 17,385 | 3.4 K to 17.4 K (+416.18 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 44.02 | 13,763 | 605,847 | 19,266 | |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 27.50 | 13,154 | 361,735 | 0 | |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 27.50 | 246 | 6,765 | 13,154 | |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 27.50 | 13,400 | 368,500 | 6,700 | |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 8.22 | 13,272 | 109,096 | 0 | |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 74.90 | 13,763 | 1,030,849 | 3,368 | 17.1 K to 3.4 K (-80.34 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 44.02 | 13,763 | 605,847 | 17,131 | 3.4 K to 17.1 K (+408.64 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 74.90 | 13,154 | 985,235 | 3,368 | 16.5 K to 3.4 K (-79.62 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 27.50 | 13,154 | 361,735 | 16,522 | 3.4 K to 16.5 K (+390.56 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 74.90 | 13,646 | 1,022,085 | 3,368 | 17 K to 3.4 K (-80.20 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 27.50 | 13,646 | 375,265 | 17,014 | 3.4 K to 17 K (+405.17 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 74.90 | 13,272 | 994,073 | 3,368 | 16.6 K to 3.4 K (-79.76 %) |
| Sep 24 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 8.22 | 13,272 | 109,096 | 16,640 | 3.4 K to 16.6 K (+394.06 %) |
| Sep 23 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 8.22 | 2,115 | 17,385 | 13,272 | |
| Sep 23 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 8.22 | 3,476 | 28,573 | 852 | |
| Sep 23 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 8.22 | 1,054 | 8,664 | 4,328 | |
| Sep 23 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Gift | G | 0.00 | 1,400 | 0 | 6,216 | 7.6 K to 6.2 K (-18.38 %) |
| Sep 23 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 74.90 | 2,115 | 158,414 | 3,368 | 5.5 K to 3.4 K (-38.57 %) |
| Sep 23 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 8.22 | 2,115 | 17,385 | 5,483 | 3.4 K to 5.5 K (+62.80 %) |
| Sep 23 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 74.90 | 3,476 | 260,352 | 3,368 | 6.8 K to 3.4 K (-50.79 %) |
| Sep 23 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 8.22 | 3,476 | 28,573 | 6,844 | 3.4 K to 6.8 K (+103.21 %) |
| Sep 23 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 74.95 | 1,054 | 78,997 | 3,368 | 4.4 K to 3.4 K (-23.84 %) |
| Sep 23 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 8.22 | 1,054 | 8,664 | 4,422 | 3.4 K to 4.4 K (+31.29 %) |
| Jun 25 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 75.50 | 4,600 | 347,300 | 10,984 | 15.6 K to 11 K (-29.52 %) |
| Jun 11 2015 | AKAO | Achaogen Inc | Smither John W | Director | Option Exercise | A | 5.53 | 10,000 | 55,300 | 10,000 | |
| Apr 30 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 45.49 | 2,041 | 92,845 | 15,584 | 17.6 K to 15.6 K (-11.58 %) |
| Apr 30 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Grant | A | 0.00 | 5,409 | 0 | 17,625 | 12.2 K to 17.6 K (+44.28 %) |
| Mar 05 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 50.00 | 1,200 | 60,000 | 12,216 | 13.4 K to 12.2 K (-8.94 %) |
| Mar 05 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 48.00 | 1,000 | 48,000 | 13,416 | 14.4 K to 13.4 K (-6.94 %) |
| Mar 05 2015 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 46.99 | 2,000 | 93,980 | 14,416 | 16.4 K to 14.4 K (-12.18 %) |
| Jul 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 8.22 | 375 | 3,083 | 7,257 | |
| Jul 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 33.40 | 375 | 12,525 | 16,200 | 16.6 K to 16.2 K (-2.26 %) |
| Jul 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 8.22 | 375 | 3,083 | 16,575 | 16.2 K to 16.6 K (+2.31 %) |
| Jul 03 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 8.22 | 2,250 | 18,495 | 7,632 | |
| Jul 03 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 40.00 | 2,250 | 90,000 | 16,200 | 18.5 K to 16.2 K (-12.20 %) |
| Jul 03 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 8.22 | 2,250 | 18,495 | 18,450 | 16.2 K to 18.5 K (+13.89 %) |
| Jun 24 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 8.22 | 375 | 3,083 | 9,882 | |
| Jun 24 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 38.06 | 375 | 14,273 | 16,200 | 16.6 K to 16.2 K (-2.26 %) |
| Jun 24 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 8.22 | 375 | 3,083 | 16,575 | 16.2 K to 16.6 K (+2.31 %) |
| Jun 16 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 4.84 | 3,000 | 14,520 | 14,017 | |
| Jun 16 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 4.84 | 3,000 | 14,520 | 16,200 | 13.2 K to 16.2 K (+22.73 %) |
| May 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 5.90 | 375 | 2,213 | 14,897 | |
| May 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 32.20 | 375 | 12,075 | 13,200 | 13.6 K to 13.2 K (-2.76 %) |
| May 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 5.90 | 375 | 2,213 | 13,575 | 13.2 K to 13.6 K (+2.84 %) |
| Apr 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 5.90 | 375 | 2,213 | 15,272 | |
| Apr 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 36.12 | 375 | 13,545 | 13,200 | 13.6 K to 13.2 K (-2.76 %) |
| Apr 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 5.90 | 375 | 2,213 | 13,575 | 13.2 K to 13.6 K (+2.84 %) |
| Mar 27 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.35 | 3,000 | 4,050 | 6,216 | |
| Mar 27 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 1.35 | 3,000 | 4,050 | 13,200 | 10.2 K to 13.2 K (+29.41 %) |
| Mar 20 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 5.90 | 1,125 | 6,638 | 15,647 | |
| Mar 20 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 43.78 | 1,125 | 49,253 | 10,200 | 11.3 K to 10.2 K (-9.93 %) |
| Mar 20 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 5.90 | 1,125 | 6,638 | 11,325 | 10.2 K to 11.3 K (+11.03 %) |
| Feb 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 5.90 | 2,250 | 13,275 | 16,772 | |
| Feb 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 49.75 | 2,250 | 111,926 | 10,200 | 12.5 K to 10.2 K (-18.07 %) |
| Feb 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 5.90 | 2,250 | 13,275 | 12,450 | 10.2 K to 12.5 K (+22.06 %) |
| Feb 18 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 5.90 | 1,125 | 6,638 | 19,022 | |
| Feb 18 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 50.00 | 1,125 | 56,250 | 10,200 | 11.3 K to 10.2 K (-9.93 %) |
| Feb 18 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 5.90 | 1,125 | 6,638 | 11,325 | 10.2 K to 11.3 K (+11.03 %) |
| Feb 13 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | A | 44.02 | 33,029 | 1,453,937 | 33,029 | |
| Jan 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 5.90 | 1,125 | 6,638 | 20,147 | |
| Jan 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 42.54 | 1,125 | 47,856 | 10,200 | 11.3 K to 10.2 K (-9.93 %) |
| Jan 21 2014 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 5.90 | 1,125 | 6,638 | 11,325 | 10.2 K to 11.3 K (+11.03 %) |
| Dec 16 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.35 | 1,200 | 1,620 | 9,216 | |
| Dec 16 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 1.35 | 1,200 | 1,620 | 10,200 | 9 K to 10.2 K (+13.33 %) |
| Nov 07 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.35 | 9,000 | 12,150 | 10,416 | |
| Nov 07 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 1.35 | 9,000 | 12,150 | 9,000 | 0 to 9 K |
| Sep 10 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.35 | 30,000 | 40,500 | 19,416 | |
| Sep 10 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.35 | 10,000 | 13,500 | 49,416 | |
| Sep 10 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 30.03 | 30,000 | 900,996 | 0 | 30 K to 0 (-100.00 %) |
| Sep 10 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 1.35 | 30,000 | 40,500 | 30,000 | 0 to 30 K |
| Sep 10 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 30.00 | 10,000 | 300,000 | 0 | 10 K to 0 (-100.00 %) |
| Sep 10 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 1.35 | 10,000 | 13,500 | 10,000 | 0 to 10 K |
| Aug 02 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Option Exercise | M | 1.35 | 10,000 | 13,500 | 59,416 | |
| Aug 02 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Sell | S | 26.80 | 10,000 | 268,005 | 0 | 10 K to 0 (-100.00 %) |
| Aug 02 2013 | KYTH | KYTHERA BIOPHARMAC ... | Smither John W | Chief Financial Off ... | Buy | M | 1.35 | 10,000 | 13,500 | 10,000 | 0 to 10 K |
Page: 1